These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 22666874)
1. Study design may explain discrepancies in GB virus C effects on interferon-γ and interleukin-2 production and CD38 expression in T lymphocytes. Bhattarai N; Stapleton JT Mem Inst Oswaldo Cruz; 2012 Jun; 107(4):568-9; author reply 569. PubMed ID: 22666874 [No Abstract] [Full Text] [Related]
2. Influence of GB virus C on IFN-γ and IL-2 production and CD38 expression in T lymphocytes from chronically HIV-infected and HIV-HCV-co-infected patients. Baggio-Zappia GL; Barbosa Ade J; Brunialti MK; Salomão R; Granato CF Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):662-9. PubMed ID: 22012219 [TBL] [Abstract][Full Text] [Related]
3. GBV-C/HIV coinfection and interferon-producing cells. Hoseini MH; Pourfatollah AA; Mohraz M Arch Med Res; 2008 Jul; 39(5):548. PubMed ID: 18514103 [No Abstract] [Full Text] [Related]
4. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients. Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286 [TBL] [Abstract][Full Text] [Related]
5. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy. d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625 [TBL] [Abstract][Full Text] [Related]
6. Effect of Hepatitis C Virus Coinfection on the Content of CD4(+) and CD8(+) T Cell Subpopulations in HIV-Infected Patients Receiving Antiretroviral Therapy. Korolevskaya LB; Shmagel KV; Saidakova EV; Shmagel NG; Slobodchikova SV; Chereshnev VA Bull Exp Biol Med; 2016 Jun; 161(2):281-3. PubMed ID: 27388630 [TBL] [Abstract][Full Text] [Related]
7. Role of GB virus C in modulating HIV disease. Schwarze-Zander C; Blackard JT; Rockstroh JK Expert Rev Anti Infect Ther; 2012 May; 10(5):563-72. PubMed ID: 22702320 [TBL] [Abstract][Full Text] [Related]
8. GB virus C: the good boy virus? Bhattarai N; Stapleton JT Trends Microbiol; 2012 Mar; 20(3):124-30. PubMed ID: 22325031 [TBL] [Abstract][Full Text] [Related]
9. Virologic and immunologic aspects of HIV-hepatitis C virus coinfection. Chew KW; Bhattacharya D AIDS; 2016 Oct; 30(16):2395-2404. PubMed ID: 27427873 [TBL] [Abstract][Full Text] [Related]
10. What is the role of GB virus C infection in hepatitis C virus/HIV coinfection? Berzsenyi MD; Roberts SK J Infect Dis; 2006 Aug; 194(4):407-9. PubMed ID: 16845622 [No Abstract] [Full Text] [Related]
12. HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells. Rallón N; García M; García-Samaniego J; Rodríguez N; Cabello A; Restrepo C; Álvarez B; García R; Górgolas M; Benito JM PLoS One; 2017; 12(3):e0173943. PubMed ID: 28323897 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection. Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507 [TBL] [Abstract][Full Text] [Related]
14. Immunology of viral co-infections with HIV. Northfield JW; Harcourt G; Lucas M; Klenerman P Arch Immunol Ther Exp (Warsz); 2005; 53(1):3-12. PubMed ID: 15761372 [TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy. Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390 [TBL] [Abstract][Full Text] [Related]
16. GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-alpha therapy. Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chang WY Antiviral Res; 2001 Dec; 52(3):241-9. PubMed ID: 11675141 [TBL] [Abstract][Full Text] [Related]
17. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection. MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305 [TBL] [Abstract][Full Text] [Related]
18. Diminished frequency of hepatitis C virus specific interferon gamma secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients. Harcourt G; Gomperts E; Donfield S; Klenerman P Gut; 2006 Oct; 55(10):1484-7. PubMed ID: 16543291 [TBL] [Abstract][Full Text] [Related]
19. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation. Martini F; Sacchi A; Lalle E; Castilletti C; D'Offizi G; Abbate I; Capobianchi MR Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541 [No Abstract] [Full Text] [Related]
20. [Interaction between HIV-1 and GB virus type-C during coinfection status]. Arroyave JC; Pujol FH; Navas MC; Cortés-Mancera FM Rev Chilena Infectol; 2013 Feb; 30(1):31-41. PubMed ID: 23450407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]